3-D Matrix, Ltd. (DMTRF)
3-D Matrix, Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Tokyo, TY, JP. The stock last traded at $2.50, up 0.00% on the session, giving a market capitalisation of $320.0M. On trailing twelve-month figures it carries a trailing P/E of 13.73, a net margin of 31.0%. Its beta of 0.99 implies it has historically moved less than the broad market.
3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications. This Tokyo, Japan-based entity was founded in 2004.
3-D Matrix, Ltd. is most often compared with the following Healthcare names: